Home
/
Bills
/

C-37

LAW

42th Parliament · Session 1

Bill C-37: An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts

Introduced

December 12, 2016

Current Stage

RoyalAssentGiven

Last Updated

May 18, 2017

Sponsor

Jane Philpott

Community Support

Community Vote

0% Support

0 votes

Politicians' Vote

61% Support

285 MPs

Support

Undecided/Abstain

Oppose

Cast Your Vote

Your vote helps inform others

Engagement

Votes

0

Comments

0

Follows

0

Parliamentary Votes

9

Statements

86

Bill C-37

Thu May 18 2017

An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts

Votes on this bill

Vote 272

Agreed To

Time allocation for Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts

Mon May 15 2017

Yeas: 193

Nays: 75

Total: 270

Vote 275

Agreed To

Motion respecting Senate amendments to Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts

Mon May 15 2017

Yeas: 173

Nays: 112

Total: 285

Vote 274

Negatived

Motion respecting Senate amendments to Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts (amendment)

Mon May 15 2017

Yeas: 78

Nays: 206

Total: 286

Vote 199

Agreed To

That the Bill be now read a third time and do pass.

Wed Feb 15 2017

Yeas: 215

Nays: 80

Total: 295

Vote 193

Agreed To

That, in relation to Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts, not more than one sitting day shall be allotted to the consideration of the report stage of the said bill and not more than one sitting day shall be allotted to the consideration of the third reading stage of the said bill and, fifteen minutes before the expiry of the time provided for Government Orders on the day allotted to the consideration of each stage of the said bill, any proceedings before the House shall be interrupted, if required for the purpose of this Order, and in turn every question necessary for the disposal of the report stage or the third reading stage, as the case may be, of the bill then under consideration shall be put forthwith and successively without further debate or amendment.

Tue Feb 14 2017

Yeas: 207

Nays: 85

Total: 292

Vote 197

Negatived

Tue Feb 14 2017

Yeas: 83

Nays: 214

Total: 297

Vote 198

Agreed To

That Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts, {as amended}, be concurred in at report stage [with a further amendment/with further amendments] .

Tue Feb 14 2017

Yeas: 214

Nays: 83

Total: 297

Vote 185

Agreed To

That the Bill be now read a second time and referred to the Standing Committee on Health.

Wed Feb 01 2017

Yeas: 216

Nays: 76

Total: 292

Vote 184

Agreed To

That, in relation to Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts, not more than one further sitting day shall be allotted to the consideration at second reading stage of the Bill; and That, 15 minutes before the expiry of the time provided for Government Orders on the day allotted to the consideration at second reading stage of the said Bill, any proceedings before the House shall be interrupted, if required for the purpose of this Order, and, in turn, every question necessary for the disposal of the said stage of the Bill shall be put forthwith and successively, without further debate or amendment.

Wed Feb 01 2017

Yeas: 206

Nays: 86

Total: 292

Sponsor

Jane Philpott

Member of Parliament

House of Commons

First reading

Completed on December 12, 2016

Second reading

Completed on February 1, 2017

Consideration in committee

Completed on February 10, 2017

Report stage

Completed on February 14, 2017

Third reading

Completed on February 15, 2017

Senate

First reading

Completed on February 16, 2017

Second reading

Completed on March 9, 2017

Consideration in committee

Completed on April 13, 2017

Report stage

Completed on May 2, 2017

Third reading

Completed on May 4, 2017

Royal Assent

Royal assent

Completed on May 18, 2017